Thrivent Financial for Lutherans’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $35.5M | Sell |
627,699
-166,953
| -21% | -$9.73M | 0.07% | 323 |
|
|
2025
Q4 | $47.2M | Buy |
794,652
+16,542
| +2% | +$901K | 0.08% | 284 |
|
|
2025
Q3 | $42.1M | Buy |
778,110
+60,428
| +8% | +$3.46M | 0.08% | 265 |
|
|
2025
Q2 | $39.5M | Buy |
717,682
+112,060
| +19% | +$6.6M | 0.09% | 266 |
|
|
2025
Q1 | $42.8M | Buy |
605,622
+560,433
| +1,240% | +$37.7M | 0.09% | 270 |
|
|
2024
Q4 | $2.97M | Buy |
45,189
+116
| +0.3% | +$7.77K | 0.01% | 1178 |
|
|
2024
Q3 | $3.17M | Sell |
45,073
-1,152
| -2% | -$96.3K | 0.01% | 1156 |
|
|
2024
Q2 | $3.81M | Buy |
+46,225
| New | +$3.85M | 0.01% | 1010 |
|
|
2023
Q3 | – | Sell |
-2,393
| Closed | -$207K | – | 2437 |
|
|
2023
Q2 | $207K | Sell |
2,393
-688
| -22% | -$64.7K | ﹤0.01% | 2400 |
|
|
2023
Q1 | $300K | Buy |
+3,081
| New | +$319K | ﹤0.01% | 2289 |
|
|
2021
Q1 | – | Sell |
-25,884
| Closed | -$2.27M | – | 2528 |
|
|
2020
Q4 | $2.27M | Buy |
25,884
+1,925
| +8% | +$153K | 0.01% | 1232 |
|
|
2020
Q3 | $1.82M | Sell |
23,959
-3,068
| -11% | -$310K | ﹤0.01% | 1209 |
|
|
2020
Q2 | $3.33M | Sell |
27,027
-111,067
| -80% | -$11M | 0.01% | 838 |
|
|
2020
Q1 | $11.7M | Sell |
138,094
-29,847
| -18% | -$2.57M | 0.04% | 466 |
|
|
2019
Q4 | $14.2M | Buy |
167,941
+25,174
| +18% | +$1.9M | 0.04% | 469 |
|
|
2019
Q3 | $9.62M | Buy |
142,767
+368
| +0.3% | +$28.3K | 0.03% | 517 |
|
|
2019
Q2 | $12.2M | Sell |
142,399
-805,278
| -85% | -$68.9M | 0.04% | 461 |
|
|
2019
Q1 | $84.2M | Sell |
947,677
-17,858
| -2% | -$1.66M | 0.27% | 88 |
|
|
2018
Q4 | $82.2M | Buy |
965,535
+639,531
| +196% | +$60.8M | 0.3% | 72 |
|
|
2018
Q3 | $31.6M | Sell |
326,004
-9,120
| -3% | -$910K | 0.1% | 225 |
|
|
2018
Q2 | $31.6M | Sell |
335,124
-889,652
| -73% | -$77.9M | 0.1% | 197 |
|
|
2018
Q1 | $99.3M | Buy |
1,224,776
+1,044,921
| +581% | +$89.7M | 0.34% | 63 |
|
|
2017
Q4 | $16M | Buy |
179,855
+8,950
| +5% | +$778K | 0.05% | 333 |
|
|
2017
Q3 | $15.9M | Hold |
170,905
| – | – | 0.06% | 307 |
|
|
2017
Q2 | $15.5M | Buy |
170,905
+23,760
| +16% | +$2.16M | 0.06% | 290 |
|
|
2017
Q1 | $12.9M | Buy |
147,145
+19,490
| +15% | +$1.73M | 0.06% | 322 |
|
|
2016
Q4 | $10.6M | Buy |
127,655
+12,240
| +11% | +$1.05M | 0.05% | 365 |
|
|
2016
Q3 | $10.7M | Buy |
115,415
+27,350
| +31% | +$2.58M | 0.05% | 360 |
|
|
2016
Q2 | $6.85M | Buy |
88,065
+2,520
| +3% | +$214K | 0.03% | 482 |
|
|
2016
Q1 | $7.06M | Buy |
85,545
+2,230
| +3% | +$181K | 0.03% | 466 |
|
|
2015
Q4 | $8.73M | Buy |
83,315
+7,650
| +10% | +$799K | 0.04% | 386 |
|
|
2015
Q3 | $7.97M | Sell |
75,665
-130,490
| -63% | -$17.4M | 0.04% | 394 |
|
|
2015
Q2 | $28.2M | Buy |
206,155
+4,230
| +2% | +$524K | 0.16% | 154 |
|
|
2015
Q1 | $25.2M | Buy |
201,925
+3,140
| +2% | +$333K | 0.14% | 174 |
|
|
2014
Q4 | $18M | Sell |
198,785
-24,668
| -11% | -$2.05M | 0.1% | 230 |
|
|
2014
Q3 | $16.1M | Buy |
223,453
+7,290
| +3% | +$479K | 0.09% | 231 |
|
|
2014
Q2 | $13.4M | Hold |
216,163
| – | – | 0.08% | 268 |
|
|
2014
Q1 | $14.7M | Buy |
216,163
+1,280
| +0.6% | +$94.3K | 0.09% | 235 |
|
|
2013
Q4 | $15.1M | Sell |
214,883
-25,700
| -11% | -$1.75M | 0.09% | 238 |
|
|
2013
Q3 | $17.4M | Buy |
240,583
+12,240
| +5% | +$813K | 0.11% | 208 |
|
|
2013
Q2 | $12.7K | Buy |
+228,343
| New | +$14.2M | 0.08% | 252 |
|
Other funds holding BMRN
VCM
VPM
